stroke
Conditions
Interventions
1Hz-repetitive transcranial magnetic stimulation (max. 2000 pulses/session
stimulus intensity, 90% resting motor threshold
target, primary motor cortex contralateral to the paretic side) 1 session/week, 4 weeks Real stimualtion vs. placebo Cross-over design Stimulator
Magstim Rapid (The Magstim Company, UK)(Code
36902000)
placebo (the stimulation coil is detached apart from the sculp or tilted 45-90 degrees to the tangential plane of the sculp)
Sponsors
Ministry of Education, Culture, Sports, Science and Technology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) chronic-stage hemiparetic stroke patient (6 months or more after onset) 2) written informed consent 3) outpatient
Exclusion criteria
Exclusion criteria: 1) severe medical illness 2) permanent pacemaker, cerebral aneurysm clipping 3) epilepsy 4) consciousness disturbance, advanced dementia or communicative difficulties 5) any other conditions unsuitable to the study judged by doctor(s)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Finger tapping speed, walking speed (3m Timed Up-and-go test) | — |
Secondary
| Measure | Time frame |
|---|---|
| FIM (Functional Independence Measure) SIAS (Stroke Impairment Assessment Set) Brunnstrom stage Manual muscle testing Finger pinch force | — |
Countries
Japan
Contacts
Public ContactTakayuki Katayama
Asahikawa Medical University First Department of Internal Medicine
Outcome results
None listed